No image published for this recall
Bd alaris
Official notice
28 Feb 2022
Last checked
28 Feb 2022
An official Health Canada notice concerns Bd alaris. Recall is being initiated to notify customers to the risk of the use and installation of unauthorized, third-party parts on the Alaris system. Recall start date: Feb 7, 2022 Published 2022-02-28.
What to do now
Contact the manufacturer if you require additional information.
Recall number
63948
Official notice
2022-02-28
The hazard
The hazard
Recall is being initiated to notify customers to the risk of the use and installation of unauthorized, third-party parts on the Alaris system. Recall start date: Feb 7, 2022
How to check if you're affected
How to check if you're affected
Compare the VIN on your vehicle against the official list. If your VIN is listed, follow the official notice.
Recall Numbers
Checked manually this time?
The app watches your VIN and alerts you automatically next time — no searching, no checking back.
Turn on automatic VIN checksAffected products
Affected products
Product 1
Product 2
Product 3
Product 4
Product 5
Product 6
Risk / hazard
Where it was sold
Where it was sold
The source does not list specific retailers. See the official notice for where affected vehicles were sold.
Location 1
Affected area 1
Company & contacts
Company & contacts
Brand
Manufacturer
Phone
Brand: Carefusion 303, Bd Alaris.
Source & status
Source & status
Source
Tier
Category
Classification
App estimate
Recall details
Recall details
Recall number
Classification
Source tier
Documents, notices & source
See the official notice and source documents for full details.
View full official noticeRelated recalls
Alaris & bd alaris point-of-care unit (pcu)
20 Feb 2026Alaris™ pump module & bd alaris™ pump module
Bd alaris™ pump module and subset of compatible pump infusion sets
Bd alaris™ pump module
Bd alaris pcu
Bd alaris™ etco2, pca, syringe, and pump modules
Bd alaris™ infusion devices
Bd alaris large volume pump
Abiomed introducer kits with impella heart pumps
Importation of chinese-authorized ifosfamide for injection due to the current shortage of canadian-authorized ifex (ifosfamide for injection)
Impella controller
Importation of us-authorized vasopressin injection, usp, 20 units ml (for IV infusion) due to the current shortage of canadian-authorized vasopressin injection, usp, 20 units ml (for im or sc administration)
Weekly recall digest
Get next week's recalls before you need them.
One email every Monday — official-source recalls for your country, and nothing else. Unsubscribe from any email.
The digest is the slow lane — one email a week. For instant, severity-gated alerts the moment a notice is published, get the app.
This recall was published 28 Feb 2022. The next one won't wait for you to search.
RecallScope watches official sources for the brands and VINs you follow, and alerts you the moment a new notice is published.
